Huckel Hubert E Md - Net Worth and Insider Trading
Huckel Hubert E Md Net Worth
The estimated net worth of Huckel Hubert E Md is at least $20 Million dollars as of 2024-04-19. Huckel Hubert E Md is the Director of Catalyst Pharmaceuticals Inc and owns about 1,304,134 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $20 Million. Huckel Hubert E Md is also the Director of ThermoGenesis Holdings Inc and owns about 4 shares of ThermoGenesis Holdings Inc (THMO) stock worth over $3. Details can be seen in Huckel Hubert E Md's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Huckel Hubert E Md has not made any transactions after 2012-05-24 and currently still holds the listed stock(s).
Transaction Summary of Huckel Hubert E Md
Huckel Hubert E Md Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Huckel Hubert E Md owns 3 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) , Titan Pharmaceuticals Inc (TTNP) , and ThermoGenesis Holdings Inc (THMO) .
Click here to see the complete history of Huckel Hubert E Md’s form 4 insider trades.
Insider Ownership Summary of Huckel Hubert E Md
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2012-05-24 | director & 10 percent owner |
| TTNP | Titan Pharmaceuticals Inc | 2003-10-20 | director |
| THMO | ThermoGenesis Holdings Inc | 2007-11-16 | director |
Huckel Hubert E Md Latest Holdings Summary
Huckel Hubert E Md currently owns a total of 2 stocks. Among these stocks, Huckel Hubert E Md owns 1,304,134 shares of Catalyst Pharmaceuticals Inc (CPRX) as of May 24, 2012, with a value of $20 Million and a weighting of 100%. Huckel Hubert E Md also owns 4 shares of ThermoGenesis Holdings Inc (THMO) as of November 16, 2007, with a value of $3 and a weighting of 0%.
Latest Holdings of Huckel Hubert E Md
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2012-05-24 | 1,304,134 | 15.34 | 20,005,416 |
| THMO | ThermoGenesis Holdings Inc | 2007-11-16 | 4 | 0.65 | 3 |
Holding Weightings of Huckel Hubert E Md
Huckel Hubert E Md Form 4 Trading Tracker
According to the SEC Form 4 filings, Huckel Hubert E Md has made a total of 0 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years. The most-recent trade in Catalyst Pharmaceuticals Inc is the acquisition of 125,000 shares on May 24, 2012, which cost Huckel Hubert E Md around $100,000.
According to the SEC Form 4 filings, Huckel Hubert E Md has made a total of 0 transactions in ThermoGenesis Holdings Inc (THMO) over the past 5 years. The most-recent trade in ThermoGenesis Holdings Inc is the acquisition of 4 shares on November 16, 2007, which cost Huckel Hubert E Md around $284,700.
Insider Trading History of Huckel Hubert E Md
- 1
Huckel Hubert E Md Trading Performance
GuruFocus tracks the stock performance after each of Huckel Hubert E Md's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Huckel Hubert E Md is 52.52%. GuruFocus also compares Huckel Hubert E Md's trading performance to market benchmark return within the same time period. The performance of stocks bought by Huckel Hubert E Md within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Huckel Hubert E Md's insider trading performs compared to the benchmark.
Performance of Huckel Hubert E Md
Average Return
-25.06%
Outperforming Transactions
25%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.55 | 52.52 | -21.69 | -25.06 | -4.93 | 1.31 |
| Relative Return to S&P 500(%) | 19.23 | 56.08 | -25.47 | -31.45 | -12.4 | -1.21 |
Huckel Hubert E Md Ownership Network
Ownership Network List of Huckel Hubert E Md
Ownership Network Relation of Huckel Hubert E Md
Huckel Hubert E Md Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
Huckel Hubert E Md is the director & 10 percent owner of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include Chief Compliance/Legal Officer Brian Elsbernd , Chief Accounting Officer Alicia Grande , and Chief Medical Officer Gary Ingenito .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, Huckel Hubert E Md made no insider transaction in Catalyst Pharmaceuticals Inc (CPRX). Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 430,000 shares made by Alicia Grande , a net sale of 105,000 shares made by David S Tierney , and a net sale of 89,666 shares made by Brian Elsbernd .
In summary, during the past 3 months, insiders sold 50,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 50,000 shares. During the past 18 months, 1,804,523 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,804,523 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
Huckel Hubert E Md Mailing Address
Above is the net worth, insider trading, and ownership report for Huckel Hubert E Md. You might contact Huckel Hubert E Md via mailing address: C/o Titan Pharmaceuticals Inc, 400 Oyster Point Blvd, S San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
